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resistant strains (MIC 256 mg/L). The moderately erythromycin- 
resistant strains were also resistant to tetracycline and hybridized with 
erm7853 and with tetQ probes. 
Conclusion: To our knowledge, this is the first time that the 
erm7853 and the tetQ related genes have been observed in C. d@cile 
strains. These results provide additional evidence of transfer of antibi- 
otic resistance genes among intestinal bacteria. 
Beta-lactamase/ESBL 
Extended-spectrum 6-lactamases (ESBLsl in 
clinical isolates of Escherichia coli and 
Klebsiella pneumoniae 
E. Andrzejewska, A. Szkaradkiewicz. Karol Marcinkowski University 
o f  Medical Sciences in Poxnan, Poland 
Objectives: Determination of frequencies of E. coli and K.  pneumo- 
niae strains which produce ESBLs, in isolates from hospitalized 
patientc, and evaluation of susceptibility of the strains to telected 
antibiotics. 
Methods: In the first trimester of 1998, 137 E. coli strains and 52 
K. pneumoniae strains were isolated from patients in four hospitals in 
Poznan, Poland. The strains were identified using ID 32 G N  tests and 
the ATB system. ESBL-producing strains were detected using the 
double-disk test with clavulanic acid as R-lactamase inhibitor. Strain 
susceptibility to selected antibiotics was determined using the disk 
diffusion technique, as specified by the NCCLS. 
Results: Three E. coli strains (2.2%) and 21 K. pneumoniae strains 
(40.4%) were producing ESBLs. All the ESBL-producing strains were 
also resistant to aniinoglycoside antibiotics and to doxycycline. High 
sensitivity of ESBL-producing E. coli strains (100%) and K.  pneunro- 
niae strains (over 70%) to fluoroqinolones was demonstrated. One 
strain of K.  pneumoniae was resistant to imipenem. 
Conclusion: Application of imipenem in treatment of E. coli 
and/or K. pneumoniae infections should be restricted to strains sensi- 
tive to the antibiotic, which produce ESBLs. 
ml Occurrence of extended-spectrum beta- 
lactamases and inducible beta-lactamases in 
clinical strains of Gram-negative rods 
M. Dolezal, J. Kedzierska, I! Kachlik. JagieNunian University 
Collegium Medicum, Cracoiv, Poland 
Objectives: To check the actual qituation concerning the occurrence 
of Grain-negative rods producing extended-spectrum O-lactamases 
(ESBL)s and inducible R-lactamases (IBLs) in clinical specimens from 
newborns hospitalized in the Department of Neonatology in 
Cracow. In addition, 1187 cases of neonates with infectional risk 
factors were retrospectively estimated in relation to the frequency of 
the systemic infections caused by Enterobacteriaceae clinical isolates 
resistant to third-generation cephalosporins. Such determinations 
have not been performed in this hospital before. 
Methods: The strains were identified in automatic ATB system 
using strips with biochemical tests. ESBL-producing strains were 
detected with the double disk diffusion test according to Jarlier et a]. 
Inducible B-lactaniases were determined using the double disk 
method according to Sanders and Sanders. 
Results: Over 2 years (1997-98), 360 strains belonging to the 
Enterobacteriacae family (64% of all strains) and non-fermenting rods 
(36%) were isolated. New groups of Gram-negative bacteria (mainly 
Enterobacter cloacae 8% and Klebsiella pneumoniae 86%) resistant to the 
majority of conimonly used 8-lactam antibiotics were found. In total, 
19% ESBL-producing strains and 30.5% strains with IBL activity 
were detected. In a study performed in the years 1993-97 in our 
hospital, 56% of Klebsiella pneumoniae isolates were producing ESBLs, 
but data obtained for particular years were dramatically different, 
varying between 11% and over 83% in 1997. A substantial increase 
in thenumber of IB-producing strains of Enterobocter cloace was 
observed in the years 1993-96 (from 58% to 91.6%). 
Conclusions: The obtained results confirm the necessity of 
continuous and reliable monitoring of ESBL- and IBL-producing 
strains among Gram-negative rods isolated from clinical materials. 
Accumulation of norfloxacin (NOR-Acl in 
extended-spectrum R-lactamase-producing 
Klebsiella pneumoniae (ESBL-Kpn) deficient or 
not in porins 
I! Joyanes, M.C. Conejo, I. Garcia, A. Pascual, L. Martinez- 
Martinez. Deparfment cf Microbiology, School $Medicine, Seuille, Spain 
Objectives: To evaluate NOR-Ac in ESBL-Kpn and the effect of 
the energy inhibitor cyanide m-chlorophenylhydrazone (CCCP) in 
this accumulation, and to study the relationship between NOR-Ac, 
porin expression, and MICs of N O R .  
Methods: Twenty-seven clinical isolates of ESBL-Kpn were stud- 
ied. MICs of N O R  were determined by microdilution (NCCLS 
guidelines). Strains for which the MIC of N O R  was 3 2  mg/L were 
considered resistant (NOR-R). Porin expression was determined by 
SDS-PAGE of purified outer membranes. ESBL production was 
detected by a reduction ofthe MIC of ceftazidime and/or cefotaxime 
by clavulanic acid. Duplicated tubes of cells were preincubated with 
N O R  (10 nig/L). One set of tubes were subsequently treated with 
CCCP (0.1 mM). Extracellular N O R  was eliminated by centrifuga- 
tion through a silicon oil barrier. NOR-Ac was measured by spec- 
trofluorometry. 
Results: Fourteen strains produced porins (7 NOR-R, 7 NOR- 
S), and 13 strains were porin deficient (8 NOR-R, 5 NOR-S). 
Ranges of NOR-Ac were 141k70 to 225k44 for 11 strains (type 
A), and 427C93 to 490588 for 16 strains (type B). CCCP deter- 
mined increased NOR-Ac in all type A strains (NOR-Ac after 
CCCP treatment: 331 +32 to 435k64). CCCP did not affect NOR- 
Ac in type B strains. Type A strains included 4 NOR-S and 7 NOR- 
R strains. Ten of 11 type A strains were porin deficient, while 13 of 
16 type B strains expressed porins. 
Conclusions: Most ESBL-Kpn strains deficient in porins show 
decreased NOR-Ac caused by an energy-dependent mechanism. 
This mechanism was observed in both NOR-susceptible and NOR- 
resistant strains. 
Relationship between R-lactamase (BLS) 
production and outer membrane protein (OMP) 
profiles and activity of carbapenems against 
Acinetobacter baumannii 
E Fernandez, M.C. Conejo, A. Pascual, E. Ramirez, L. Martinez- 
Martinez, E.J. Perea. Department ofhfiirubiology, Scliool ofhfedicine, 
Seuille, Spain 
Objectives: To investigate the relationship between imipenem 
(IMP) and meropenem (MPM) activity and BLS production and 
O M P  profiles in Acinezo6acter banmnmmii (Ai3). 
Methods: Twenty-six AB strains, representing antibiotypes and 
pulsotypes of organisms isolated from blood during 1995-97, were 
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studied. Strains were biotyped according to Bouvet and Grimont. 
MICs of ticarcillin (TIC), ceftazidime (CAZ), IMP and MPM, alone 
or combined with clavulanic acid (CA) or BRL.12715 (BRL), were 
determined by microdilution. OMPs were separated by SDS-PAGE. 
PIS of BLS were determined by isoelectric focusing (pH 3-9). 
Hydrolyis of IMP was determined by spectrophotometry and by a 
iiiicrobiological dssay. 
Results: Five biotypes were identified: 9 (n=9),  6 (a=)(), 2 (n=6),  
18 (n=2) and 11 ( n = l ) .  MICws (mg/L) were: 512 (TIC, TIC=CA, 
CAZ, CAZ=CA), 128 (TIC=BKL, CAZ=BRL), 16 (IMP, 'Hcispital Principes de Espana, Belluige, Barcelonu, Spi t7  
Japan and also emphasizes the urgent need for early recognition of 
strains producing these enzymes. 
F] Extended-spectrum-B-lactamase-producing K. 
pneumoniae outbreak in a cardiopediatric ICU 
A. Oliver', J.C. Perez-Diaz', A. Asensio', E Baquero', M.A. 
Dominguez', R. Canton'. 'Hozpitai Ramori y C+i, itlaadrid, 
IMI'=CA), 8 (MI'M, MPM=CA), 4 (MPM=BRL) and 11.5 
(lMP=BRL). Four OMP profiles were observed: A (n=19), B 
(t2=5), C (n=l)  and D (ti=l). Four out of five isolates with profile 
B (characterized by the absence of a 25-kDa OMP) were resistant to 
carbapenems (MICs IMP and MPM=8 mg/L). All isolates had BLS 
with pl5 of either 9 or 8.3. Thirteen isolates additioiially had a ULS 
of pl 6.3, and in sonie cases other BLS (pls: 6.8 and 5.4). Hydrolysis 
of IMP (mU/mg protein) in all 13 isolates containing the BLS 0.3 
was higher (0.1-0.7) than in isolates lacking the 6.3 BLS (not 
detectable to 0.00). MICs (ing/L) of IMP and MPM for isolates 
containing the 6.3 BLS ranged from 4 to 32. and for isolates lacking 
the 6.3 BLS from 0.06 to 2. 
Conclusions: Resistance of AH to IMP (but not MPM) is 
reverted by BKL. Decreased activity of carbapenems in  AB i\ asso- 
ciated with a BLS of pI 6.3 and in some cases with the los\ of a 25- 
kDa O M P  
wl Metallo-R-lactamases in Pseudomonas 
aeruginosa: a new problem for Europe 
G. Cornaglia, G Ainicosante, R. Fontana, A. MdZZariO1, L. 
Laurrtti, P Piccoh, M.L. Riccio, G.M. Rossolini. Iwiture of 
Microbiolcyy, Unitwsrty of I ?rona; Department .f Srirncc und Medical 
TPrfit7olyy, L'ttitwsiiy L .4qui/a; Dcgarfment .f hfokcnlar Biolqy, 
Lhivcrsity of Sietiu, Italy 
A niultidrug-resistant heirdonionas aewginosa strain (VR 143/97) with 
unusually high-level resistance to imipenein (MIC 256 mg/L) was 
isolated from a surgical wound of a patient adinittcd to the intensive 
care unit of the Verona University Hospital. A crude cell-free extract 
prepared from this strain exhibited imipenein- hydrolyzing activity, 
which was almost completely inhibited by treatment with EIITA and 
w~is restored hy addition of Zn'+ to the EDTA-treated sample. A 
blalM,.-specific probe did not hybridize to strain V R  1.13/97 in a 
colony blot may, indicating that a metallo-carbapenemase other than 
IMP-1 was produced by this strain. 
From March 1997 to February 1998, a further 9 isolates ofP derns- 
iriora \howiiig high-level reristance to imipenem (MICs 118- 
256 mg/L) were cultured in samples of patients from different w'irds 
of the sanie hospital. All strains were resistant to piperacillin, 
piper~cilliii/tazobactam, ticarcillin/clavulanate, ceftazidime, cefepinie, 
imipenem, and ineropenem. 
The DNA fingerprinting patterns of XOauI-digested total DNA 
preparation by PFGE for the 9 isolates suggest that 8 of the 9 strains 
were clonally related to the index strain. Cloning and sequencing of 
the gene encoding the new metallo-carbapmeniase (bla1,wz) was 
undertaken and primers dcrived from the sequence were used in 
amplification reactions of strains' DNA. P C R  aiialysis confirmed the 
presence of blal~pr  in all str~iiis, including the non-genetically reiated 
strain. This suggested that the gene was apparently transferable, at 
least among I! n e r ~ ~ ~ t n m u  strains. 
The nosocomial outbreak we describe, preceded by the isolation 
of a multidrug- resistant carbapenrmase-producing I? aerqinosa strain 
in the UK, confirms the emergence of new carbapenemases outside 
Introduction: An extended-spectruni-l~-l~ctaii~ase-producing K. 
pnerrniuniue (ESUL-Kp) outbreak (October 1997 to March 1998) was 
detected in the cardiopediatric ICU from our horpital. 
Materials and methods: Screening for colonization/infection 
was performed with 1 mg/L ceftazidimc MacConkey agar plates. 
MICs for different R-lactam and aminoglycoside antibiotics were 
determined according to the NCCLS guidelines. Tranwonjugantc 
(nalidixic acid- and kanamycin-resistant E. cvli MC4100) and trans- 
formants (E .  coli TG-1) were obtained. O-Lactainase isoelectric 
focusing was performed with the PhastSystem (Pharmacia). Blai,..~, 
primers were used on plasniid DNA of the transformant\ to amplify 
the fi-lactanme gene. To assess the relatedness between the ESBL- 
Kp isolates, random amplified polymorphic DNA (RAI'D) and 
pulsed-field gel electrophoresis (PFGE) were performed. 
Results and conclusions: Colonization/infection with the 
ESBL-Kp isolate was detected in 10 patients. Microbiology screen- 
ing, patient isolation, personnel handwashing measures and changes 
in antibiotic use limited the outbreak. The susceptibility profiles 
(range MICs, mg/L) of the ESBL-Kp isolate\ were ac follows: 
ceftazidime, 16-64; cefotaxime, 32-128; aztreonam, 16-32; co- 
amoxiclav, .1/1-8/4; cefoxitin, 4-8; iinipeneni, < =U.25; grntamicin, 
8; tobraniicin, 8; and ainikacin, < =4. Oxi-imino-Il-lactani and 
aniinoglycoside resistances were co-transferred by conjugation and 
transformation. A single TEM-type R-lactamase band of j . 9  was 
observed in the ESBL-Kp transconjugants and transformants. IlAPD 
and PFCE demonstrated similar patterns in all the ESBL-Kp isolate\. 
[w Post-R-lactamase inhibition effect (PLIE) of 
clavulanic acid against R-lactamase-producing 
strains of Klebsiella pneumoniae and 
Haemophilus influenzae 
E Jehl, V Murbach, N. Dhoyen, L. Linger, H. Monteil. ~ ! ~ h ~ i r a r o r y  
o f , 4 n f i h i o l q ~  of the Instirnte o f  Bactrrioloxy, liniversity Hospirul cf 
Strasboircq, France 
The PLIE could be one among many factors explaining why the 13- 
Iactaniin/l~-lactaniase inhibitor combinations remain effective in vivo 
after serum concentrations ofinhibitor have fallen below levels which 
are active in vitro. The purpose of this study was to mvertigate 2nd 
characterize the in vitro PLIE ofclavulanic acid (CA) againqt R-lacta- 
niase-producing strains: K. gnetrnioniae (MIC values: anioxycillin 
(AMX) 256 mg/L; CA 64 mg/L; AMX-CA 4 mg/L) and H .  i r ~ f l m t -  
zut' (MIC values: AMX 32 mg/L; CA 32 mg/L; AMX-CA 1 mg/L). 
A stationary-phase inoculuni of about lo7 of each bacterium 
served as a CA=l mg/L controller or was pre-exposed for 2 h to 
either CA alone or CA plus AMX at various concentration\: K.  pnru- 
rnoriiae CA 2 or .1 nig/L, AMX 4.8 or 16 n~g/L;  H. it&mrzae CA 
0.5, 1 or 2 mg/L, AMX 1, 4, 8 or 16 mg/L. The dilution needed to 
remove the I3-lactaniase inhibitor or both druG was 10.' or 1W3 
according to the strain The hourly bacterial counts following the 
removal of drugs were carried out on solid ruppleinented agar media. 
Control cultures were exposed to AMX alone after dilution arid 
showed a regrowth delay (RD), possibly due to the time needed by 
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bacteria to syntheslze B-lactamases in sufficient amounts after dilu- 
tion. Control experiments allowed us to clearly differentiate PLIE 
from postantibiotic effect (PAE) or from RD. 
RD values ranged from 0.5 h to 1.5 h for K. pneumoniae, and from 
0 h to 13 h for H. injuenza. PAE-0 for K. pneumoniae, but the values 
for H. injuenza ranged from 1 b to 5 h. PLIE vales for K. pneumo- 
niae ranged from 0 h to 5 b, while the values for H. intuenza ranged 
from 0 h to 15 h These data, differing from previously published 
results, suggest the existence ofan authentic PLIE different from RD 
and PAE, as proved by results obtained after the pre-exposure to CA 
alone. 
ml Antimicrobial susceptibility of Escberichia coli 
(Ec) and Klebsiella pneumoniae (Kp) clinical 
isolates producing extended-spectrum beta- 
lactamases (ESBLsl in a pediatric hospital in 
Greece 
E. Lebessi, E. Bozavoutoglou, S. loannidou, T.H. Zagouris, N. 
Xenos, M. Foustoukou. Department of Microbiololy, l? C A. Kyriakou 
Children's Hospital, Athens, Greece 
Objectives: To evaluate the emergence of Ec and Kp isolates 
producing ESBLs in various wards in our hospital and their in vitro 
susceptibility to antimicrobials over a I-year period (November 1397 
to October 1998). 
Methods: Thirty-eight Ec and 74 Kp non-repetitive strains 
producing ESBLs, isolated from 98 patients, were tested by the disk 
diffusion method to 18 antimicrobials according to NCCLS recom- 
mendations. MICs were determined using a commercially available 
microdilution system (Sensititre, West Sussex, UK). ESBLs were 
detected by the double-disk synergy test (DDST). 
Results: O f  ESBL producers, 75% were recovered at neonatal and 
oncology units, while 3.5% were from PICU patients. MICYI and 
MICgo values (mg/L) of cefotaxime (Cx), ceftazidime (Caz), 
cefepime (Fep), amikacin (Ak), gentamicin (Gn), tobramycin (Tb), 
piperacillin/tazobactani (Tzp), irnipenem (Imp) and ciprofloxacin 
(Cip) were as follows: 
dpoaoxadn (Ciol werr as follows: 
Cx Caz Fa Ak Gn "b Tzp Imp Cip 
Ec MICs 54 >I6 0.5 16 4 >8 1214 50.25 10.06 
m w  32 >I6 4 32 >8 >8 W4 10.25 S0.M 
Kp MICa 54 >I6 I 8 2 8 534 50.25 50.06 
bfICr0 16 >I6 4 16 >8 >8 16/4 10.25 50.06 
Conclusions: DDST is necessary, since ESBL producers often 
have low-level resistance to third-generation cepbalosporins and may 
be mis-identified. Antimicrobial agents, such as Fep, Imp, Cip and 
Tzp, remain extremely active. 
I P88 I Detection of extended-spectrum beta- 
lactamase (ESBL)-producing strains at the 
Military Medical Academy, Sofia, Bulgaria 
R. Vacheva, E. Savov. Military Medical Academy, Sofa, Bulgaria 
Objectives: This study presents data on the prevalence of ESBL- 
producing strains (65 of family Enterobacteriaceae) at MMA-Sofia 
for a 9-month period and compares two methods of detection. 
Methods: The microorganisms were investigated by the Mini API 
system (BioMerieux, France). The double-disk (DD) test and ATB- 
BLSE (BioMerieux, France) were used. The ATB-BLSE method 
shows the recovery by sulbactam determining the MIC of antibiotic 
(aztreonam and crftazidime) on its own and in the presence of an 
inhibitor. 
Results: The 44 ESBL-producing strains were recovered from: 
endotracheal aspirates (16), urine (13), surgery wounds (1 l) ,  blood 
(2), and bile (2). Klebsiella pneumoniae is prominent among all ESBL- 
positive isolates (90.7%). The most ESBLpositive isolates originated 
from the ICU (47.7%) and surgery clinics (25%). 
Conclusions: During the 36-week period, 4.2% of all isolates 
produced ESBLs. The DD method is useful and less expensive. The 
ATB-BLSE method (first time in our country) provided more sensi- 
tivity, automated reading and epidemiologic analysis. This test is 
useful for selecting strains for future molecular analysis. 
wl Antimicrobial susceptibilities and Wactamase 
content of Yersinia strains isolated from 
aquatic environments 
E. Tzelepi', M. Arvanitidou*, A. Mavroidi', A. Tsakris3. 'Hellenic 
Institute Pasteur, Athens; Departments of2Hygiene and 3Microbiology, 
Medical School, Aristotelian University, Thessaloniki, Greece 
Objectives: Studies related to B-lactamase content of the previously 
named 'k:enterocolitica-like' species and in particular of Yersinia inter- 
media have not appeared in the literature. We report susceptibilities 
and B-lactamase contents of Y enterocolitica and k: intermedia isolated 
in aquatic environments of Greece. 
Methods: Thirty-seven Yersinia spp. strains (seven Y enterocolitica 
and 30 Y intermedia) isolated from various aquatic environments were 
biotyped, serotyped and tested for their susceptibility. Screening for 
induction and inhibition of R-lactamase expression was performed by 
double-disk tests, and B-lactamase content was analyzed by isoelec- 
tric focusing. 
Results: O n  the basis of combined biotyping/serotyping results, 
Y enterocolitica isolates were scattered in five and Y intermedia in 17 
groups. Various patterns of B-lactam insensitivity were detected, 
including ampicillin and ticarcillin (35 isolates), cephalothin (33). 
carbenicillin (32), amoxycillin/clavulanate (23), and cefoxitin (22). 
No correlation between biotype or serotype and the susceptibility 
pattern of the isolates was apparent. In all cases two distinct B-lacta- 
inase bands were detected, presumably a penicillinase and a 
cephalosporinase, with pls varying from 9 to 9.5 for the former and 
from 5.5 to 7.8 for the latter. Accordingly, by disk diffusion syner- 
gism tests, both inducible cephalosporinase activity against third- 
generation cephalosporins and inhibition of resistance to penicillins 
were detected in all Y enterocolitica and Y intermedia isolates. 
Conclusions: The above data indicate that two 6-lactamases, 
analogous to those previously described in clinical strains of Y ente- 
rocolitica, are also present in Yersinia spp. from environmental sources; 
variations in susceptibility profiles occur, probably due to quantita- 
tive differences in their production. 
I P90 I Detection of extended-spectrum 13-lactamases 
(ESBLs) among enterobacteria: comparison of 
the Vitek ESBL and double-disk tests 
A. Kemeroglou', D. Sofianou', J. Douboyas2, E. Tzelepi", A. 
Tsakri4. 'Hippokration General Hospital, Aristotelian University, 
Thessaloniki, 'AHEP'A General Hospital, Aristotelian University, 
Thessaloniki, 'Hellenic Pasteur Institute, Athens, 4Department of Medical 
Microbiolo.qy, Aristotelian University, Thessaloniki, Greece 
Objectives: There is great interest in developing tests for the detec- 
tion of ESBL-producing enterobacteria. The Vitek ESBL test has 
been proven a reliable indicator for the presence of ESBLs among E .  
coli and Klebsielh pneumoniae strains. In our  region, the presence of 
ESBLs among enterobacteria is very high and there are indications 
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of their spread airiong species other than E. coli and K. pncrrirroni'ie. 
I n  this respect, we evaluated the ability of the Vitek ESBL test to 
detect ESBLc in comparison with the double-disk test. 
Methods: Standard Vitek ESUL and double-disk tests werr 
performed oii 218 enterobacterial isolates from clinical cpeciinens in 
hospital\ of Thessaloniki, Greece. In casec of discrepant results, both 
testc were repeated. Strains with discrepant results after repeat testing 
wcre analyzed for 0-lactamase production after conjugal trancfer of 
resistance. 
Results: O f  the 2% strains examined (77 E. coli, 75 K. ~mct in~o-  
iliac, 33 Eiitcr~ibartcr cluacoe, 7 E. urngenes and 36 other enterobacte- 
ria), OH strains (12 E. mli, 43 K .  pneumnnije, 2 E. rloarae and one 
Serrariu rnarsccccizs), were found to produce ESBLs by both tests. I n  
five cases (4 E. r lorw and one E. a i w p ~ c s ) .  the double-disk test WJY 
positive, while the Vitek ESBL test failed to detect ESRLs. Further 
analysis by coiijugal transfer, hydrolytic activity and analytic isoelec- 
tric focusing showed that these strains possesscd ESULc. 
Conclusions: It seems, that in some instances, derepressed AinpC 
B-lactanrase\ in our E~itcrobartcr strains inask detection of ESBLs by 
the Vitek ESUL test. 
F l  serratia marcescens in a tertiary care 
hospital-study over 2 years 
L. Nauniiuk, A. Samet, M. Dronk, 1. Nalewajcka. Drpartmeiir qf 
Clinical Bncfcriolo,rl)~, S r m  Hospiral N o .  1 ,  Gdansk, Poland 
Objectives: To evaluate the frequency of Serratia morrescctis isolation 
in coniparison to other nosocoiiiial pathogens during a ?-year 
period. 
Methods: Our study was peiformed in a 1201-bed tertiary care 
hospital from 1995 to 1996. We reviewed our laboratory records to. 
assess the frequency of S. marrescrris infection and/or colonization in 
different wards and compare it to other nosoconiial pathogens-S. 
riiarrcseeri.y isolates froin 22 ICU patients in 1996 were genotyped by 
RAI'U-PCK. 
Results: In 1996 we observed a twofold increase in isolation of 
S. martestens compared to 1995: 276 and 140 respectively. 
IClJ Suww-Y UNIS General Mallcine-8 unib ouler urutsd umts 
1YY5 1w 75 47 18 
19% 245 135 121 20 
The most frequent sitec of isolation were: respiratory specimens 
(224), drains ( tY6) ,  urine (13), blood (77) and wounds (69). The rxe  
of S. niercestens isolation from blood in 1996 (3.4%) equaled the rates 
for hfudoiiioirar acvlqiiiyirrosa (3.3%) and Acinetohacter baumaiuiii (3.6%) 
but was still lower than those for Estlwrirhia eoli (4.6%) aiid 
Stupliylococcits airreto (8.5"h). P C R  genotyping revealed the persistence 
of one predoiiiinant strain responsible for infections in 18 ICU 
pativim in 1996. 
Conclusions: Iluring the studied period, S. mnrccstrii~ became 
one  of the iiioht frequent nosocoiiiial pathogens in our hospital. This 
was probably due to the spread of endemic clones as a result of crosc- 
contaniination and transfer of colonized patients between units. 
Infections caused by S. marccsce~ir were difficult to eradicate despite 
targetcd antimicrobial therapy which might havr contributed to 
increased serratia isolations. 
ml In vitro activity of piperacillinltazobactam 
against Klebsiella pneumoniae clinical isolates, 
producers or not of extended-spectrum beta- 
lactamases 
T. Alarcon, I? de la Obra, S. Lopez, C. dc Ias C:ucvcn, M. Lopez- 
Urea. Hospiral dc la Priricesu, i2lirrnhiolo~y, itfadrid, S)airi 
The aim of this study was to determine the in vitm .ictivity of 
piperacillin/tazobactani againjt 81 clinical isolates of K .  prr~~miioni~w. 
The clinical cpeciiiirns received at the Microbiolo~y Ilepartiiient in 
the Hospital Universitxio de la Princc\a were processed .icxording 
to standard microbiological procedures, and 81 K. prrciiriiorriac i\olate\ 
were identified by Microscan Panels following the in.inuCictiirer\' 
recomniendatiom. A double-ditk diffusion nicthod wa, ~ipplled to 
detect extended-spectrum beta-lactaniaws (43 isolate\ were positive 
and 38 were negative). Minimum inhibitory concentr.ition\ (MlCs) 
were deterinined by an agar dilution technique nrmg Mucller- 
Hinton agar. The inoculurri was applied with a Steer replicator a id  
plates were incubated at 37°C for 18 h. The following antibiotics 
were studied: piperal.illin/tazobactan (P/T), diiioxycilliniclavulaiii~ 
acid (AMC), cefotaxime (CTX), ceftriaxone (CRO), cefepune 
(CPI), iniipeneiii (IMP) and meropenem (MEK). 
Results: The MICws were 16/4 mg/L for P/T, l h / H  for AMC, 
16 for CIW, 16 for CTX, 4 for CPI, 0.25 for IMP .ind 0.031 for 
MEK in ESUL-positive strains, 2nd 4/4 nig/L for P/T, 814 fur AMC:, 
0.064 for CRO, 0.125 for CTX, 0.125 for CPI, 0.11.5 for IMP and 
0.016 for M E R  in ESBL-negative strains. The  percentage of suscep- 
tibility was 25.6?'0 for AMC, 81.4% for CTX, 83.H"~ for C I W ,  93.l",b 
for P/T, 97.73; for CPI and 100?h for IMP aiid M E R  in ESLIL- 
producing K. pncirniurriae, aiid 92.1% for AMC and 100'>~1 for CTX, 
CRO, CPI, IMP, MEK and P/T in ESBL non-producer K .  pur- 
monine. 
Conclusions: All beta-lactams showrd excellent iii vitro activity 
againgt ESBL-producing A?. przenniuriiar. Moreover, piperacilliii/ 
tazobactani, cefepime and both carbapeneins showed good i n  vitro 
activity against EBSL-producing K. prrertmoriint. 
FI Antimicrobial susceptibility to beta-lactams 
and beta-lactamases in Acinetobacter 
baumannii 
S. Lopez-Hernandez, T. Almmn, T. Delgado, M. Lopez-Urea 
Hospital di, la Prinrcsa, M i r r o l d q y ,  ,%ladrid, Sparti 
Objective: To study the antimicrobial susceptibility tu beta-lactams 
(ULM) and the production of beta-lactaniasz\ (BLS) i n  .+irrcvolmttr 
bnumanrrii clinical isolates. 
Methods: O n e  hundred and tifty-six strains from diifcreiit clini- 
cal samples were studied. The  MICs of mipicillin (AMP). ticarcillin 
(TIC), piperacillin (PIP), ampici~~in-su~b.ictain (AS), amoxycillin- 
clavulmic acid (AMC), ticarcillin-clavulairic ncid (TIU;L),  
piprracillin-t~zobact~iii (TZI'), cefotaxiine (CTX), ccftazidniic 
(CAZ), cefcpiiiie (CEF), imipeneni (IMP) and meropenem (MEP) 
were determined by an agar dilution method according to NCCLS 
recomiiiendations. BLS production wa\ studied by nitmcetin hydrol- 
ysis in crude soiiic extracts, and pl was deterinincd by i\oelcctric 
focusing (polyacrylaniide gel%. 3.5-9.5). Inhibitory profilcs of ULS to 
clavulanic acid (CLAV), cloxacillin (CLOXA), sulhactmi (SULH) a n d  
aztreonani (AZT) were determined hy J spcc.trophotomctric ci\\.iy. 
Results: A low antimicrobial susceptibility to most tlLM was 
observed: AMP 1 .9";1: TIC 10.8%: PIP 10.2%: AS X4.6'!,0; AMC 
14.1%; TICCL 33.9"'o; TZP 37.8'!6; C T X  8.Y'h:  <:AZ 15.3"~; CEF 
17.3%: IMP 88.4"i); MEP 89.l'jh. Thc a\sociation of ELM wlth 
inhibitors did not increase the \usceptibility. Most \trains were BLS 
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positive (92.9%). A chromosomic cephalosporinase (Cse), with PI 8, 
inhibited by CLOXA and AZT but not by CLAV and SULB, was 
demonstrated in 81.4% of the strains. Cse=TEM-1 (PI 5.4) was 
demonstrated in only one strain. A BLS with PI 7.7 not inhibited by 
inhibitors was shown by 10.2% of isolates. This percentage corre- 
sponded to strains with high-level resistance to carbapenems. One 
strain with low-level resistance to carbapenems showed a different 
BLS with PI 6.8, also not inhibited by inhibitors. 
Conclusions: Chromosomic cephalosporinases predominate in 
these A. bauntannii isolates and are correlated with low antimicrobial 
susceptibility to beta-lactams. The resistance to carbapenems is due 
to two novel BLS which confer different degrees of resistance to 
carbapenems 
wl Description of two beta-lactamases in 
carbapenem-resistant Acinetobacter baumanni 
strains 
S. Lopez-Hernandez, T. Alarcon, P Vargas Diaz, M. Lopez-Brea. 
Hospital de la Prineesa, Microbiolofy, Madrid, Spain 
Objectives: To describe two novel beta-lactamases (BL) in 
carbapenem-resistant Acinetobacter 6aumannii ( C u b )  clinical isolates 
that were not epidemiologically related. 
Methods: Two strains of CRAb (no. 38 and no. 113) were stud- 
ied. The MICs of imipenem (IMP), meropenem (MEP), cefotaxime 
(CTX), ceftazidime (CAZ), amoxycillin-clavulanic acid ( M C ) ,  
ticarcillin (TIC), ticarcillin-clavulanic acid (TICCL), piperacillin 
(PIP), piperacillin-tazobactam (TZP) and ampicillinsulbactam (AS) 
were determined by an agar dilution method according to NCCLS 
recommendations. The isoelectric point (PI) was studied on crude 
sonic extracts by isoelectric focusing (polyacrylamide gels, 3.5-9.5). 
Inhibitory profiles of BL to clavulanic acid (CLAV), cloxacillin 
(CLOXA), sulbactam (SULB), aztreonam (AZT) and EDTA were 
determined by the nitrocefin assay. The specific enzymatic activity of 
benzylpenicillin and cefaloridine was determined by a spectrophoto- 
metric analysis, and the hydrolysis of CTX, CAZ, carbenicillin 
(CARB), oxacillin (OXA), IMP and MEP was studied by a micro- 
biological assay 
Results: The results of MIC determinations (mg/L) in strains no. 
38 and no. 113 were, respectively: IMP 16, 128; MEP 8, 128; CTX 
64,128; CAZ 16,128; AMC 128,128; TIC 512,512; TICCL 1024, 
1024; PIP 128,256; TZP 16,256; AS 2,8.  BL ofboth strains showed 
respectively a PI of6.8-7 and 7.7. The percentages ofinhibition were, 
respectively: CLAV 3, 7; CLOXA 18.7, 10.1; AZT 12.4, 9.5; SULB 
14, 14.8; EDTA 12 and 13.2. Both BL showed a predominant peni- 
cillinase activity. The hydrolysis of IMP, MEP, CARB and OXA was 
demonstrated in both BL, and the hydrolysis of C T X  was observed 
in BL of strain no. 113. 
Conclusions: Two novel ‘serin-beta-lactamases’ are implicated in 
the resistance to carbapenems in A. baumannii. These enzymes are 
penicillinases with similar biochemical characteristics, but they differ 
in the level of resistance to carbapenems and cephalosporins 
wl Transfer of ceftazidime and cefotaxime 
resistance from multiresistant hemolytic 
Escherichia coli producing extended-spectrum 
beta-lactamases 
J. Blahovh’, K. Krhlikovi’, V. KrcmPry’, K. Kubonoviz. ’Institute of 
Preventive and Clinical Medicine, ’Direr’s University Clinic, Bratislava, 
Slovak Republic 
Objectives: The strain of hemolytic Esckerickia coli was studied 
during a systematic survey of production and transferability of 
extended-spectrum beta-lactamase (ESBL) in ceftazidime-resictant 
Enterobacteriaceae. 
Methods: E .  coli No. 151 was isolated in DCrer’s University 
Hospital in Bratislava. Antimicrobial susceptibility testing was 
performed by the disk diffusion test. The relative rate of hydrolysis 
of antibiotics was estimated by the macro-iodometric method. ESBL 
profiling ofstrains was performed using the double disk diffusion test. 
Transfer of genes for antibiotic resistance was pefiormed in mixed 
liquid cultures. Cells of the donor and recipient strain were mixed in 
nutrient broth and the mixture was incubated overnight and then 
plated on agar with rifampicin plus one of the antibiotics present in 
the resistance spectrum of the donor strain. Transconjugant colonies 
were recorded after overnight incubation. As recipient strains we used 
E.  coli K-12 No. 3110 rif+ and Proteus mirabilis P-38 [if+. 
Results: E .  roli No. 151 was resistant to the following beta- 
lactams-carbenicillin, cephalotin, cephazolin, cefuroxime, cefo- 
taxime, ceftazidime and aztreonam-and directly transferred to both 
recipient strains the resistance to carbenicillin, cephalotin, cefo- 
taxime, ceftazidime and aztreonam. The relative rate of hydrolysis of 
cefotaxime, ceftazidime and aztreonam in E. coli No. 151 was inhib- 
ited after the addition of clavulanate almost to zero values. The 
double-disk diffusion test demonstrated the presence of ESBL 
hydrolyzing cefotaxime and aztreonam in the original strain E. coli 
No. 151 and also the presence of ESBLs hydrolyzing cefotaxime, 
ceftazidime and aztreonam in transconjugant clones of E. coli K-12 
or Protcus mirabilis P-38 recipient strains. 
Conclusions: Production of extended-spectrum beta-lactamases 
in E .  coli No. 151 and their conjugative transfer to susceptible recip- 
ient strains shows the possibility of spread of antibiotic resistance in 
clinically important Enterobacteriaceae in the hospital environment. 
F l  In vitro activity of ceftazidime, cefepime and 
aztreonam against extended-spectrum beta- 
lactamase-producing nosocomial Klebsiella 
pneumoniae 
J. Blahovi’, €? Jezek’, K. Kubonova’, J. Hanzen4, H. Hupkova5. 
‘Institute of Preventive and Clinical Medicine, Bratislava, Slovakia; 
’Hospital Dribram, Creck Republic; ‘Dererk University Hospital, 
Bratislava, Slovakia; 4 H P L  co.; 5St Cyril and Method Hospital, 
Bratislava, Slovakia 
Objectives: To evaluate the in vitro activity of ceftazidime, cefepime 
and aztreonam in ESBL-producing K .  pneumotziae isolates from vari- 
ous hospitals. 
Methods: MICs were determined by an agar dilution method 
with 2-fold dilutions of antibiotics. To visualize the presence ofESBL 
in strains, the double-disk diffusion test was used. 
Results: From 50 K .  pneumoniae isolates, 24 were isolated in 
Hospital Pribram, Czech Republic, and 26 in different hospitals in 
Bratislava. MICs of 50 Kle6sieilu pneumoniae isolates were as follows: 
MIC (nig/L) 
4 8 16 32 64 128 256 
Ceftazidime (n)  5 3 3 7 7 3 22 
A b s t r a c t s  1 1 1  
Cefepiiiie (N) 15 11 8 2 5 3 6 
Aztreonaiii (n) 4 4 1 5 4 5 27 
n=nuinber of isolates 
Production of ESBLs was positive in 41 of these isolates in vari- 
ous combinations of inhibition of beta-lactaniases by clavulanic acid 
(cla). In 41 case? production of beta-lactamase hydrolyzing cefo- 
tdxime was indicated, hydrolysis of aztreonam was demonstrated in 
28 isolates, in 4 isolates production of beta-lactaniase hydrolyzing 
cefiazidime was indicated, and 33 isolates showed production of 
ESBL hydmlyzing cefepime, despite the susceptibility of some 
isolates to this drug. The most frequent pattern of ESBL production, 
i.e. three zones of inhibition (cla/cefotaxinie, cla/cefepime and 
cla/aztreonaxii) w3s observed in 20 isolates. 
Conclusions: From three compared beta-lactanis, cefepime was 
the most effective antibiotic against K. pnermoniae isolates studied. 
Several outbreaks caused by ESBL-producing 
Enterobacteriaceae strains in a Warsaw 
hospital 
A. Palucha'. B. Mikiewicz2, W Hryniewicz', M. Gniadkowski'. 
'Scru G kffirres Ccrztral Raearc/i Laboratory, 'Health Caw Cenfre 2'ra.p 
Polrioc, I.Vnrsau4 Polarid 
Objectives: To characterize ESBL-producing Enterobacteriaceae in 
a large hospital extensively using expanded-spectrum cephalosporins. 
Methods: Thirty-five isolates belonging to seven different 
Enterobacteriaceae species were collected as all ESBL producers over 
a period of 4 months (1996-97) in a hospital in Warsaw. MICs of 
beta-lactains arid aminoglycosides were evaluated by the agar dilution 
method. Isolates were typed by RAPD and subjected to mating 
experiments. Beta-lactamase content was studied by IEF; ESBL 
activity was detected by the bioassay approach. ESBL families were 
identified by PCR. Plasiiiid DNA was purified from a representative 
group of isolates and subjected to fingerprinting analysis. 
Results: Two different types of ESBL were identified in the 
analyzed isolates. One of these, with a PI of 8.4, has determined a 
specific resistance phenotype with MlCs of cefotaxime much higher 
than those of ceftazidime. The 8.4 beta-lactaniases belonged to the 
CTX-M family of ESBLs and most probably were the CTX-M-3 
enzyme. They were produced by 27 isolates of all identified species. 
The hlaCTX-M genes were located on very similar large conjugative 
plasmids conferring alyo resistance to aininoglycosides. The high 
prevalence of CTX-M producers in the hospital has resulted froin 
both plasniid dissemination and clonal spread of several strainc of 
different species. SHV enzymes with a PI of 8.2 represented the other 
ESUL type. These were produced by non-related Klebsiellu ptrerrmo- 
tiiae dnd E. coli strains carrying plasmids of various fingerprints. These 
strains could have emerged by independent selection or have been 
introduced from other hospitals. 
Conclusions: A high consuinption of broad-spectrum cephalo- 
sporins together with lack of ESBL monitoring procedures before 
1996 have resulted in a complex epidemiology of ESBL-producing 
microorganisms in Polish hospitals. 
Ip981 In vitro activity of cefotetan against 
enterobacteria with extended-spectrum beta- 
lactamases 
Etiterobacteriaceae, especially klebsiellae and Proreus niirabilis. Thc 
aim of the present study was to determine the in vitro activity of 
cefotetan against ESBL-producing clinical isolates. 
Methods: The activity of cefotetan was assessed against 140 recent 
clinical isolates of eriterobacteria collected during a multicenter 
survey in Italy The presence of an ESBL wac tested by the double- 
disk potentiation method and subsequently coiifirmed. The minimal 
inhibitory concentrations (MICs) were determined by the agar dilu- 
tion niethod for cefotetan and 13 other antimicrobial agents, includ- 
ing ccfoxitin, cefepinie, ceftriaxone, ceftazidime, imipeiiem, 
ineropenem, amikacin and ciprofloxacin. On selected strains the 
influence of inoculum size (lo5 versus lo7 CFU/spot), the minimal 
bactericidal concentrations and the time-kill curves were also deter- 
mined. 
Results: Cefotetan was highly effective against the strains tested, 
exerting a rapid bactericidal effect. Its MICil, and MIC,,,, were 0.5 
and 2 mg/L respectively, its activity being superior to that of cefox- 
itin (4-32 mg/L), comparable to that ofiniipenem (0.5-4 mg/L) and 
weaker only than that of nieropenem (0.06-0.2s nig/L). For the 
strains studied, a high rate of cross-resistance was observed between 
extended-spectrum cephalosporins, gentamicin ( 5  1.8%)) and 
ciprofloxacin (40.3%). 
Conclusions: Cefotetan had excellent activity against ESUL- 
producing Enterobacteriaceae and may be clinically useful in treat- 
ing infections caused by these organisms. 
mj Antibiotic susceptibility of 64 
Stenotrophomonas maltophilia strains 
determined by Etest and the agar dilution 
method according to R-lactamase production 
and R-lactam phenotype 
T. Fosse, 11. Carles, Archef2 Hospital, Buctcriolq~/, R'ice, Fratice 
This study evaluated the susceptibility of 64 Srcnorrophotnonas 
mahph i l ia  strains to ticarcillin (TIC), ticarcillin-clavulanate (TIM), 
iniipeneiii (IMP), ceftazidime (CAZ), latanioxef (MOX), tobraniycin 
(TOU). ciprofloxacin (CIP), tetracycline (TET) and rifaiiipiii (KIF) 
by Etest and conventional agar dilution methods. Plates were read 
after 24 h of culture at 37°C. B-Lactain phenotype? were deduced 
from susceptibility to TIC, CAZ, MOX, IMP aiid aztreonam with 
and without clavulanic acid and B-lactaiiiase production (isofocaliza- 
tion). When results were analyzed as percentages of strains suscepti- 
ble at the breakpoint, 80-90'% agreement between the methods was 
observed. However, when MIC ratios were analyzed, correlations 
were poor, with 41% (TIM), 72% (CAZ) and 91% (CIP) of Etest 
MIC results within f 2  dilutions of the reference agar dilution. 
Among B-lactain antibiotics, ticarcillin-clavulanate was found to be 
the most active by the two methods with 75% of susceptible strains. 
It was less active on L1 and/or L2 high-level O-lactatiiase-producing 
strains. MIC distributions were slightly different for the two nicth- 
ods for most antibiotics and depended on B-lactain phenotype and/or 
Ii-lactam induction. Due to the great variability of O-lactamase 
expression, the choice of susceptibility method for S. maltuphilia 
deserves further study. 
G. Privitera, E. Come, M.L. Kanzi, E. Mascheroni, A. Pagano, 
Utriuersiry .f Mifati, Iirstituic ~$Hxyiiene, Mifurr, Iraly 
Objectives: Extended-spectrum beta-lactamases (ESBLs) are an 
increasing cause of resistance to third-generation cephalosporins iii 
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(P1001 Cloning and sequencing of the gene encoding 
a novel Oxa-type beta-lactamase isolated from 
Aeromonas caviae 
T. Fosse, C. Giraud, M. Cassar, ArchetZ Hospital, Bacteriology, Nice, 
France 
An Aeromonas caviae (AC) strain (P239), which presented a beta- 
lactam phenotype characterized by resistance to ampicillin, ticarcillin 
and cephalothin (MICs 64 mg/L), was studied for cloning ofthe gene 
responsible for beta-lactamase production. After chromosomal DNA 
preparation, two genes encoding a typical cephalosporinase enzyme 
and a new Oxa-type beta-lactamase were cloned into pCLL2300 
(respectively 2.5 and 1.8-kb insert) and expressed into E .  coli JM109. 
This later beta-lactamase (Oxa-Cav) had a PI of 8.5, in the same range 
(8-9, PAGE isofocusing) as A. sobria and A .  hydrophila oxacillinase- 
producing strains. Oxa-Cav enzyme from the cloned gene was well 
expressed and hydrolyzed beta-lactam antibiotics such as oxacillin, 
ampicillin, ticarcillin, cephalothin and aztreonam but not cephalothin 
or cefotaxime. Beta-lactamase activity was inhibited by clavulanic 
acid. The nucleotide sequence of the gene was found to be only 70% 
homologous to the sequence of Oxa-12 (A. jandeg and amps (A. 
sobria) previously described. The deduced protein sequence, which 
contained amino acid motifs common to other plasmid or chromo- 
somal-mediated class D beta-lactamases, revealed 76% identity with 
Oxa-12, 74% with amps and less than 40% with other class D beta- 
lactamases. As previously suggested, this report confirms that 
Aeromonar caviae may produce at least two beta-lactamases. 
Oxacillinase-type beta-lactamase appears to be ubiquitous in 
Aeromonas species. 
IP101) Extended spectrum beta-lactamases (ESBLs) in 
clinical isolates of Enterobacteriaceae 
B. Tomanovic, V Mirovic, N. Miljkovic, T. Tomasevic. Military 
Medical Academy, Belgrade, Yugoslavia 
Objectives: To study the prevalence of ESBLs in clinical isolates of 
Enterobacteriaceae isolated during 1997. 
Methods: Seventy-one isolates of Escherichia coli, 69 Klebsiella 
pneumoniae, 34 Serratia marcescens, 31 Enterobacter spp.. 30 Proteus 
mirabilis, 21 Citrobacter spp., 16 Providencia spp. and 10 Klebsiella oxytoca 
were tested for production of ESBLs by double-disk synergy test 
performed with ceftriaxone, cefotaxine, ceftazidime and amoxy- 
cillin-clavulanate disks. 
Results: ESBL production was observed in 8.4% Escherichia coli, 
59.4% Klebsiella pneumoniae, 44.1% Serratia marcescens, 25.8% 
Enterobacter spp., 20% Proteus mirabilis, 28.6% Citrobacter spp., 6.2% 
Providencia spp. and 20% Klebsiella oxytoca isolates; 57% ESBL produc- 
ers would have been reported to be susceptible to ceftazidime and 
61% to cefotaxime according to the routine susceptibility method. 
Conclusions: Our results confirm the need for reliable tests in 
the detection of ESBL-producing strains. 
(=I Multiresistant KIebsiella pneumoniae 
(extended-spectrum beta-lactamaso positive) 
in the intensive care untit 
G.J. van Asselt, C.L. Jansen, J.A.E.M. Mutsaers, W.H.E Goossens. 
Medical Center Haaglanden, T h e  H a p e ;  Academic Hospital D$zzicht, 
Rofterdam, Tne Netherlands 
Objectives: To describe the impact of extended-spectrum beta- 
lactamase (ESBL)-positive, niultiresistant Kk6siella pneumoniae 
(MRKP) in the intensive care unit (ICU), and typing of strains. 
Methods and results: In 21 ICU patients an ESBL-positive 
MRKP was isolated during a period of 4 months. Resistance to 
gentamicin was found in 20 of the 21 strains. Results of RAPD, plas- 
mid restriction fragment analysis and integron PCR of these and 
other isolates point to: (1) a cluster of identical isolates from 20 ICU 
patients; (2) a second type from one ICU patient; (3) a third unre- 
lated type. Among the infections caused by MRKP were pneumo- 
nia, (uro)sepsis, brainabces, meningitis, and infected prostheses. The 
MRKP was found in surgical patients mainly (multi-trauma, neuro- 
surgery, aneurysm aorta operations). Most patients were ventilated 
(14/20). The period of ventilation of patients with MRKP was 27 
days (without MRKP 7 days). The MRKP caused serious, compli- 
cated infections in 8 patients (5 died), while 12 patients had either 
carriage or an easy-to-treat infection. The MRKP caused fdure of 
initial antibiotic treatment and failure of selective decontamination 
(SD) of the digestive tract in ventilated patients. 
Conclusions: Risk factors for MRKP were major surgery, venti- 
lation, SD of the digestive tract, and third-generation cephalosporins. 
Barrier precautions stopped the spread of MRKP. 
1p103) Comparison of screening methods for 
detection of extended-spectrum 13-lactamares 
(ESBLs) 
J. Ruczkowska, I .  Dolna, B. Kowalska-Krochma. Department of 
Microbiology, Wroclaw University $Medicine, Wroclaw, Poland 
Objectives: To compare the expediency and cost-benefit ratio of 
the Etest and double-disk synergy test (DDT) in the diagnosis of 
ESBL producers among clinical isolates. 
Methods: 3637 Gram-negative rods isolated from various mate- 
rials from patients hospitalized in 12 different clinics in the period 
April 1997 to June 1998 were tested by: the disk-diffision method 
for antibiotic susceptibility (NCCLS), DDT (amoxycillin clavulanic 
acid versus aztreonam, cefotaxime, ceftazidime and cefmiaxone) for 
ESBL and E-test (AB Biodisk, Sweden) for ESBL. ESBL production 
was first detected by DDT in 192 (5.3%) of 3637 examined strains, 
and then DDT-positive results of 100 selected strains were coun- 
terchecked with Etest strips containing ceftazidime 1 clavulanic acid 
combination (TZ 1 TZL). ESBL (+) MIC T Z  TZL 4. 
Results: In the group of 100 strains ESBL positive by DDT, Etest 
was positive in 82, negative in 3 and inconclusive in 15. Resistance 
to antibiotics used in DDT was 54%, 65%, 43% and 74% respectively, 
to aminoglycosides 75-80%. Susceptibility to carbapenems was 94%, 
moxalactam 85%. ciprofloxacin 84%. piperacillin tazobactam 75%. 
Conclusion: DDT as a part of the routine susceptibility tests is 
sufficient for ESBL screening; E-test is 20 times more expensive than 
DDT. 
